SK Bioscience will also entrust production of COVID-19 vaccines from global pharmaceutical companies next year. SK Bioscience announced on the 5th that it has signed an extension contract for the use of Andong L House facilities with CEPI in Brussels, Belgium. It will extend the period of using some of the undiluted production facilities in Andong, which were signed in June last year and are about to expire at the end of this year, to the end of 2022 for the production of COVID-19 vaccines by CEPI-supported companies.

The contract said that by the end of next year, three of SK Bioscience's facilities in L-house will be used first to entrust production of the COVID-19 vaccine developed by a company supp